Literature DB >> 3814493

Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.

A Z Rohatiner, M A Richards, M J Barnett, A G Stansfeld, T A Lister.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3814493      PMCID： PMC2002077          DOI： 10.1038/bjc.1987.42

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  18 in total

1.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors:  T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

Review 2.  Pharmacokinetics and side effects of interferon in man.

Authors:  T C Merigan
Journal:  Tex Rep Biol Med       Date:  1977

3.  Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

Authors:  S E Jones; Z Fuks; M Bull; M E Kadin; R F Dorfman; H S Kaplan; S A Rosenberg; H Kim
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

4.  Nodular non-Hodgkin's lymphoma (NHL): factors influencing prognosis and indications for aggressive treatment.

Authors:  R A Rudders; M Kaddis; R A DeLellis; H Casey
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

5.  Efficacy of combined interferon cyclophosphamide therapy after diagnosis of lymphoma in AKR mice.

Authors:  I Gresser; C Maury; M Tovey
Journal:  Eur J Cancer       Date:  1978-01       Impact factor: 9.162

6.  Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.

Authors:  T A Lister; M H Cullen; M E Beard; R L Brearley; J M Whitehouse; P F Wrigley; A G Stansfeld; S B Sutcliffe; J S Malpas; D Crowther
Journal:  Br Med J       Date:  1978-03-04

7.  Combined interferon--antimetabolite therapy of murine L1210 leukemia.

Authors:  L M Slater; M W Wetzel; T Cesario
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

8.  Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.

Authors:  R C Young; R E Johnson; G P Canellos; B A Chabner; H D Brereton; C W Berard; V T DeVita
Journal:  Cancer Treat Rep       Date:  1977-09

9.  Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease.

Authors:  T J Priestman
Journal:  Lancet       Date:  1980-07-19       Impact factor: 79.321

10.  Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial.

Authors:  S J Horning; T C Merigan; S E Krown; J U Gutterman; A Louie; J Gallagher; J McCravey; J Abramson; F Cabanillas; H Oettgen
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860
View more
  2 in total

Review 1.  The management of follicular lymphoma.

Authors:  A Z Rohatiner; T A Lister
Journal:  Drugs       Date:  1994       Impact factor: 9.546

2.  A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.

Authors:  A Rohatiner; J Radford; D Deakin; H Earl; S B Love; O Price; A Wilson; T A Lister
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.